We are live on ! Find out more
SFG

SVB Financial Group Portfolio holdings

AUM $434K
1-Year Est. Return 277.67%
This Fund
S&P 500
This Quarter Est. Return
-14.67%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$36.6M
AUM Growth
–
Cap. Flow
+$45.6M
Cap. Flow %
124.56%
Top 10 Hldgs %
92.47%
Holding
30
New
30
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$21.4M
2
OKTA icon
Okta
OKTA
+$6.4M
3
ROOT icon
Root
ROOT
+$5.4M
4
AXSM icon
Axsome Therapeutics
AXSM
+$2.02M
5
FROG icon
JFrog
FROG
+$1.71M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 49.1%
2 Technology 25.7%
3 Healthcare 20.41%
4 Industrials 2.94%
5 Consumer Discretionary 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COIN icon
1
Coinbase
COIN
$39.5B
$14.4M 39.37%
+406,973
New +$21.4M
OKTA icon
2
Okta
OKTA
$25.6B
$7.65M 20.92%
+112,012
New +$6.4M
ROOT icon
3
Root
ROOT
$954M
$3.52M 9.61%
+783,012
New +$5.4M
AXSM icon
4
Axsome Therapeutics
AXSM
$11B
$2.61M 7.14%
+33,849
New +$2.02M
FROG icon
5
JFrog
FROG
$10.4B
$1.6M 4.38%
+75,198
New +$1.71M
DICE
6
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$1.32M 3.61%
+42,358
New +$1.38M
CMAX
7
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$1.09M 2.99%
+10,000
New +$1.49M
PL icon
8
Planet Labs
PL
$7.97B
$749K 2.05%
+172,097
New +$891K
OWLT icon
9
Owlet
OWLT
$160M
$493K 1.35%
+62,961
New +$783K
ROVR
10
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$387K 1.06%
+105,534
New +$453K
NOGN
11
DELISTED
Nogin, Inc. Common Stock
NOGN
$327K 0.89%
+21,220
New +$340K
CRBU icon
12
Caribou Biosciences
CRBU
$160M
$295K 0.81%
+47,051
New +$419K
CGEM icon
13
Cullinan Oncology
CGEM
$1.08B
$285K 0.78%
+27,032
New +$328K
KROS icon
14
Keros Therapeutics
KROS
$198M
$223K 0.61%
+4,653
New +$217K
KLRS
15
Kalaris Therapeutics
KLRS
$99.7M
$221K 0.6%
+1,870
New +$317K
GBIO
16
DELISTED
Generation Bio
GBIO
$208K 0.57%
+5,292
New +$278K
MLTX icon
17
MoonLake Immunotherapeutics
MLTX
$1.49B
$170K 0.46%
+16,173
New +$144K
KNTE
18
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$143K 0.39%
+23,382
New +$190K
FIRY
19
Firy Inc
FIRY
$154M
$139K 0.38%
+13,697
New +$252K
SLNA
20
DELISTED
Selina Hospitality PLC Ordinary Shares
SLNA
$136K 0.37%
+50,217
New +$249K
PRDS
21
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$132K 0.36%
+77,880
New +$98.7K
PET
22
DELISTED
Wag!
PET
$130K 0.36%
+42,262
New +$118K
ELDN icon
23
Eledon Pharmaceuticals
ELDN
$266M
$93.1K 0.25%
+40,613
New +$100K
PACB icon
24
Pacific Biosciences
PACB
$404M
$83.8K 0.23%
+10,249
New +$88.3K
VERO
25
DELISTED
Venus Concept
VERO
$51.2K 0.14%
+970
New +$43.6K
1
2

Similar funds

RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
CBFP
Cedar Brook Financial Partners Cleveland, Ohio $698K AUM 46.64% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
SLA
SWaN & Legend Advisors Leesburg, Virginia $841K AUM 23.47% 1-Year Est. Return
SG
Stagwell Group Miami Beach, Florida $913K AUM 49.68% 1-Year Est. Return
AFG
AFS Financial Group Bethesda, Maryland $1.15M AUM 23.97% 1-Year Est. Return
K
Kemper Chicago, Illinois $1.2M AUM 20.64% 1-Year Est. Return
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

SVB Financial Group's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for SVB Financial Group, which disclosed 30 positions worth $36.6M. Its ten largest holdings account for 92% of the portfolio.

Its largest position is Coinbase: 406,973 shares worth $14.4M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, followed by Technology and Healthcare.

  • SVB Financial Group's largest Q4 2022 buy was Coinbase: 406,973 shares worth $14.4M.
  • SVB Financial Group's ten largest holdings make up 92% of its $36.6M portfolio in Q4 2022.
  • SVB Financial Group disclosed 30 positions in Q4 2022, its first 13F filing on record.

Based on SVB Financial Group's 13F filing for Q4 2022, filed 14 Feb 2023.